Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly.

Galassi A, Ciceri P, Fasulo E, Carugo S, Cianciolo G, Cozzolino M.

Drugs Aging. 2019 Jul 15. doi: 10.1007/s40266-019-00696-3. [Epub ahead of print]

PMID:
31304565
2.

The Key Role of Phosphate on Vascular Calcification.

Cozzolino M, Ciceri P, Galassi A, Mangano M, Carugo S, Capelli I, Cianciolo G.

Toxins (Basel). 2019 Apr 9;11(4). pii: E213. doi: 10.3390/toxins11040213. Review.

3.

Hyperphosphatemia: a novel risk factor for mortality in chronic kidney disease.

Cozzolino M, Ciceri P, Galassi A.

Ann Transl Med. 2019 Feb;7(3):55. doi: 10.21037/atm.2018.06.50. No abstract available.

4.

HABITAT: An IoT Solution for Independent Elderly.

Borelli E, Paolini G, Antoniazzi F, Barbiroli M, Benassi F, Chesani F, Chiari L, Fantini M, Fuschini F, Galassi A, Giacobone GA, Imbesi S, Licciardello M, Loreti D, Marchi M, Masotti D, Mello P, Mellone S, Mincolelli G, Raffaelli C, Roffia L, Salmon Cinotti T, Tacconi C, Tamburini P, Zoli M, Costanzo A.

Sensors (Basel). 2019 Mar 12;19(5). pii: E1258. doi: 10.3390/s19051258.

5.

Uremic Patients with Increased Vascular Calcification Score Have Serum with High Calcific Potential: Role of Vascular Smooth Muscle Cell Osteoblastic Differentiation and Apoptosis.

Ciceri P, Galassi A, Alfieri C, Messa P, Cozzolino M.

Blood Purif. 2019 Feb 6:1-8. doi: 10.1159/000497229. [Epub ahead of print]

PMID:
30726841
6.

Vitamin K in Chronic Kidney Disease.

Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S.

Nutrients. 2019 Jan 14;11(1). pii: E168. doi: 10.3390/nu11010168. Review.

7.

Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation.

Auricchio S, Giovenzana ME, Pozzi M, Galassi A, Santorelli G, Dozio B, Scanziani R.

Clin Kidney J. 2018 Dec;11(6):874-880. doi: 10.1093/ckj/sfy045. Epub 2018 Jul 18.

8.

Percutaneous microwave ablation of renal angiomyolipomas in tuberous sclerosis complex to improve the quality of life: preliminary experience in an Italian center.

Ierardi AM, Petrillo M, Coppola A, Angileri SA, Galassi A, Padovano B, Volpi A, Cozzolino M, Carrafiello G.

Radiol Med. 2019 Mar;124(3):176-183. doi: 10.1007/s11547-018-0967-3. Epub 2018 Dec 11.

PMID:
30539412
9.

Cardiovascular disease in dialysis patients.

Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A.

Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174.

10.

Septic cardiomyopathy: The value of lactoferrin and CD15 as specific markers to corroborate a definitive diagnosis.

Galassi A, Turatello L, De Salvia A, Neri M, Turillazzi E, La Russa R, Viola RV, Frati P, Fineschi V.

Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418776526. doi: 10.1177/2058738418776526.

11.

Troponin I Levels in Asymptomatic Hemodialysis Patients.

Castini D, Persampieri S, Floreani R, Galassi A, Biondi ML, Carugo S, Cozzolino M.

Blood Purif. 2017;44(3):236-243. doi: 10.1159/000480225. Epub 2017 Sep 29.

PMID:
28957803
12.

The Cardiovascular Burden in End-Stage Renal Disease.

Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F.

Contrib Nephrol. 2017;191:44-57. doi: 10.1159/000479250. Epub 2017 Sep 14. Review.

PMID:
28910790
13.

Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.

Galassi A, Bellasi A, Ciceri P, Pivari F, Conte F, Cozzolino M.

Expert Rev Clin Pharmacol. 2017 Oct;10(10):1073-1084. doi: 10.1080/17512433.2017.1371011. Epub 2017 Sep 4. Review.

PMID:
28846459
14.

[CKD-MBD, cardiovascular involvement and prognosis].

Bellasi A, Mangano M, Galassi A, Cozzolino M.

G Ital Nefrol. 2017 Mar;34(Suppl 69):150-161. Review. Italian.

PMID:
28682036
15.

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.

Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A.

Ther Clin Risk Manag. 2017 Jun 1;13:679-689. doi: 10.2147/TCRM.S108490. eCollection 2017. Review.

16.

Phosphate in Chronic Kidney Disease Progression.

Cozzolino M, Foque D, Ciceri P, Galassi A.

Contrib Nephrol. 2017;190:71-82. doi: 10.1159/000468915. Epub 2017 May 23. Review.

PMID:
28535520
17.

Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease.

Bellasi A, Galassi A, Mangano M, Di Lullo L, Cozzolino M.

Curr Drug Metab. 2017;18(7):680-688. doi: 10.2174/1389200218666170427112735. Review.

PMID:
28460623
18.

Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, Cozzolino M.

J Nephrol. 2017 Oct;30(5):677-687. doi: 10.1007/s40620-017-0404-z. Epub 2017 Apr 21. Review.

PMID:
28432640
19.

Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?

Cianciolo G, Galassi A, Capelli I, Schillaci R, La Manna G, Cozzolino M.

Curr Vasc Pharmacol. 2018 Jan 26;16(2):143-156. doi: 10.2174/1570161115666170310092202. Review.

PMID:
28294047
20.

Laparoscopic Left Hemicolectomy for Colon Cancer in Peritoneal Dialysis Patients: A Valid and Safe Surgical Technique to Ensure Peritoneal Dialysis Survival.

Auricchio S, Mari G, Galassi A, Dozio B, Pozzi M, Maggioni D, Scanziani R.

Perit Dial Int. 2016 11-12;36(6):695-699.

Supplemental Content

Loading ...
Support Center